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Published studies from different centers in Saudi Arabia have reported contradicting results regarding glomerular 
lesions. In this retrospective study, we report our experience in King Fahd Hospital of the University at Al-Khobar 
in the Eastern province, including a description of the morphologic and clinical characteristics of primary and 
secondary glomerular disease. The study included 233 renal biopsies obtained from patients presenting with 
glomerular manifestations over a period of 23 years (1986–2008), investigated by light microscopy, immuno-
fluorescence (149 cases) and electron microscopy (34 cases). One hundred and eighty-seven cases (80.3%) were 
primary glomerulonephritides. Minimal change glomerulopathy was the most common type of primary glom-
erulonephritis found (29.4% of primary glomerulonephritides), followed by mesangioproliferative glomerulo-
nephritis (19.8%), and focal/segmental glomerulosclerosis (15.5%). Membranoproliferative glomerulonephritis 
was found in 9.6% of cases, membranous glomerulopathy in 8.6%, IgA nephropathy in 6.4%, end-stage glom-
erulopathy in 5.9%, crescentic glomerulonephritis in 3.2%, and IgM nephropathy in 1.6%. Of the secondary 
glomerulonephritides (46 cases constituting 19.7% of the biopsies), lupus nephritis was the most frequently 
diagnosed disease (71.7% of secondary glomerulonephritides). Diabetic glomerulosclerosis was found in 10.9% 
of cases, amyloidosis in 6.5%, and Alport syndrome in 4.3%. Wegener’s granulomatosis, Henoch-Schönlein 
purpura nephritis and hypertensive nephrosclerosis each represented 2.2% of cases (one case each). Other than 
a significantly higher incidence of minimal change glomerulopathy and lupus nephritis (p < 0.001) and a sig-
nificantly lower prevalence of membranoproliferative glomerulonephritis (p = 0.029), our results are generally 
comparable to those reported by the Saudi registry for glomerulopathy and in some neighboring countries. Age- 
and sex-adjusted analyses revealed that minimal change glomerulopathy and lupus nephritis were also the most 
prevalent primary and secondary glomerulopathies in the pediatric age group (below 15 years) as well as in 
adults, females and males. [Hong Kong J Nephrol 2010;12(1):20–30]
Key words: crescentic glomerulonephritis, glomerulonephritis, glomerulopathies, 
primary glomerulonephritis
Departments of 1Pathology, 2Internal Medicine, and 3Family and Community Medicine, College of Medicine, King Faisal 
University, Dammam, Saudi Arabia.
Correspondence to: Dr. Ibrahim Saeed, Department of Internal Medicine, King Fahd Hospital of the University, King Faisal 
University, Al-Khobar 31952, Saudi Arabia.
E-mail: isaeed99@yahoo.com
Hong Kong J Nephrol • April 2010 • Vol 12 • No 1 21
 Glomerular disease: King Fahd Hospital experience
INTRODUCTION
Glomerular diseases are the leading cause of end-stage 
renal disease globally. Cases in which the kidneys are 
the predominant organs involved are known as primary 
glomerulonephritides (glomerulopathies) and constitute 
the most common form of glomerular disease. Primary 
glomerular diseases include several types that vary widely 
with regard to the morphology of the glomerular lesions. 
The glomeruli may also be injured during the course of 
a number of systemic diseases, e.g. autoimmune disorders 
such as systemic lupus erythematosus, vascular diseases 
like hypertension, metabolic diseases like diabetes mel-
litus and hereditary diseases such as Alport syndrome. 
The glomerular lesions in these cases constitute second-
ary glomerular diseases.
Studies published so far from different centers in 
Saudi Arabia concerning glomerular disease have re-
ported conflicting results regarding the types of primary 
and secondary glomerular lesions encountered. Herein, 
we report our experience in King Fahd Hospital of the 
University (KFHU) at Al-Khobar in the Eastern province, 
including a description of the morphologic and clinical 
characteristics of primary and secondary glomerular 
disease, and compare this with studies reported from 
other parts of the Kingdom and from some other coun-
tries. Located in the Eastern Province of Saudi Arabia, 
KFHU is one of the leading teaching hospitals in the 
Kingdom serving a population of about 170,000.
MATERIALS AND METHODS
In this retrospective study, 233 renal biopsies obtained 
from patients who presented with glomerular manifes-
tations to KFHU over a period of 23 years (1986–2008) 
were investigated. Cases with transplanted kidneys were 
not included in the study. Clinical, laboratory, and pho-
tographed immunofluorescence and electron microscopic 
findings were retrieved from patients’ files, while origi-
nal or newly prepared paraffin sections were reviewed 
under a light microscope by one pathologist experienced 
in renal pathology (MS).
The indications for biopsy were: nephrotic syn-
drome, proteinuria of more than 1 g/day with active urine 
sediment, systemic disease with renal involvement, and 
unexplained renal insufficiency. Histologic evaluation 
by light microscopy was available in all cases, combined 
with direct immunofluorescence in 149 cases and elec-
tron microscopy in 34 cases. Light microscopic evalu-
ation was performed on standard paraffin sections stained 
with hematoxylin and eosin and by the periodic acid-
Schiff (PAS), Masson’s trichrome and Jones methe-
namine silver techniques. Immunofluorescence included 
studies performed on frozen sections using FITC-labeled 
anti-IgG, IgM, IgA and C3 antibodies. In cases in which 
immunofluorescence and/or electron microscopic data 
were unavailable, paraffin sections of the biopsies were 
reviewed by all five pathologists participating in the 
study under a 10-headed light microscope and a con-
sensus about the diagnosis was established.
Glomerular diseases were classified using the diag-
nostic criteria formulated by the World Health Organi-
zation [1]. Statistical analysis was performed using the 
SPSS software program (SPSS Inc., Chicago, IL, USA). 
Descriptive and nonparametric statistics were adopted.
RESULTS
Of the 233 cases studied, 118 (50.6%) were male and 
115 (49.4%) were female. The age ranged from 7 to 70 
years. The clinical presentations of patients included: 
nephrotic syndrome, proteinuria, hematuria, acute renal 
failure, rapidly progressive glomerulonephritis, impaired 
renal function, chronic renal failure, and hypertension, 
singly or in various combinations.
There were 187 cases (80.3%) of primary glomer-
ulonephritides. Minimal change glomerulopathy was 
the most common type of primary glomerulonephritis 
(observed in 55 cases, 29.4% of primary glomeru-
lonephritides), followed by mesangioproliferative 
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glomerulonephritis (37 cases, 19.8%) and focal/segmen-
tal glomerulosclerosis (29 cases, 15.5%). Membrano-
proliferative glomerulonephritis was found in 9.6% of 
cases (18 cases), membranous glomerulopathy in 8.6% 
(16 cases), IgA nephropathy in 6.4% (12 cases), end-
stage glomerulopathy in 5.9% (11 cases), crescentic 
glomerulonephritis in 3.2% (6 cases), and IgM neph-
ropathy in 1.6% (3 cases).
In the pediatric age group (< 15 years of age), the most 
common primary glomerulopathy was minimal change 
glomerulopathy (Figure 1), seen in 12 out of a total of 
25 cases (48%), followed by mesangioproliferative glom-
erulonephritis, focal/segmental glomerulosclerosis, IgA 
nephropathy and IgM nephropathy, each seen in three 
cases (12%), and finally membranoproliferative glom-
erulonephritis in only one case (4%). Membranous glom-
erulopathy, crescentic glomerulonephritis and end-stage 
glomerulopathy were not encountered in the pediatric 
age group. It should be noted that minimal change glom-
erulopathy was also the most common primary glom-
erulopathy in adults (≥ 15 years of age), seen in 43 out 
of 162 cases (26.5%).
Minimal change glomerulopathy was also the most 
prevalent primary glomerulopathy encountered in fe-
males (Figure 2), in 30 out of 83 (36.1%), followed by 
mesangioproliferative glomerulonephritis (18, 21.7%), 
membranoproliferative glomerulonephritis (9, 10.8%), 
focal/segmental glomerulosclerosis (8, 9.6%), membra-
nous glomerulopathy (6, 7.2%), IgA nephropathy and 
end-stage glomerulopathy (4 patients each, 4.8%), and 
finally crescentic glomerulonephritis and IgM nephropa-
thy (2 each, 2.4%). Minimal change glomerulopathy was 
also the most common primary glomerulopathy encoun-
tered in males, seen in 25 out of 104 cases (24%).
Of the secondary glomerulonephritides (46 cases, 
constituting 19.7% of the biopsies), lupus nephritis was 
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Figure 1. Frequency distribution in the pediatric age group (< 15 years old) of: (A) primary glomerulonephritides; (B) secondary 
glomerulonephritides. GN = glomerulonephritis; GS = glomerulosclerosis; HSP = Henoch-Schönlein purpura.
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Figure 2. Frequency distribution in females of: (A) primary glomerulonephritides; (B) secondary glomerulonephritides. GN = glomerulonephritis; 
GS = glomerulosclerosis; HSP = Henoch-Schönlein purpura; HTN = hypertension.
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the most frequently diagnosed disease (33 cases, equ-
ivalent to 71.7% of secondary glomerulonephritides). 
Diabetic glomerulosclerosis was found in five cases 
(10.9%), amyloidosis in three cases (6.5%), and Alport 
syndrome in two cases (4.3%). There was one case (2.2%) 
each of Wegener’s granulomatosis, Henoch-Schönlein 
purpura nephritis, and hypertensive nephrosclerosis.
The frequency distribution and the clinical and epi-
demiologic data of the various primary and secondary 
glomerular diseases encountered are shown in Table 1.
Lupus nephritis was the most common secondary 
glomerulopathy seen in the pediatric age group (Figure 1), 
encountered in three out of four cases (75%), followed 
by Henoch-Schönlein purpura nephritis in one case 
(25%). No other secondary glomerulonephritides were 
encountered in this age group. Lupus nephritis was also 
the most frequently found secondary glomerulopathy 
in adults, seen in 31 out of 46 cases (67.4%), and in males 
(8 out of 14 cases, 57.1%). It was also by far the most 
common secondary glomerulopathy encountered in 
females (Figure 2), seen in 25 out of 32 cases (78.1%), 
followed by diabetic glomerulosclerosis and amyloido-
sis (2 patients each, 6.3%), and finally Alport syndrome, 
Henoch-Schönlein purpura nephritis and hypertensive 
nephrosclerosis in one patient each (3.1%).
Minimal change glomerulopathy
Patients with minimal change glomerulopathy had an 
age range between 7 and 61 years, with a mean age of 
27.2 ± 12.9 years; 25 (45.5%) were male and 30 (54.5%) 
were female. The majority of cases (85.5%, 47 patients) 
presented with nephrotic syndrome, which was steroid 
dependant/resistant in 18.2% of cases (10 patients) and 
associated with bilharzial liver disease in one case 
(1.8%), and type II diabetes mellitus in another (1.8%). 
Proteinuria was the presenting manifestation in 14.5% 
of cases (8 patients), associated with hematuria in 5.5% 
of cases (3 patients), hypertension in 3.6% (2 patients), 
and recurrent urinary tract infection in 1.8% (1 patient). 
All glomeruli appeared to be essentially normal on light 
Table 1. Frequency distribution and epidemiologic and clinical data of primary and secondary glomerulonephritides
Disease Patients,  Age (yr),  Male,  Female,  Clinical picture
 n (%) mean ± SD (range) n (%) n (%)
Primary (n = 187)
   Minimal change GN 55 (29.4) 27.2 ± 12.9 (7–61) 25 (45.5) 30 (54.5) NS (85%), proteinuria, 
     hematuria, HTN
   Mesangioproliferative GN 37 (19.8) 31.5 ± 13.8 (7–70) 19 (51.4) 18 (48.6) NS (62%), proteinuria, 
     hematuria, HTN, SCD, CRF
   FSGS 29 (15.5) 32.1 ± 11.8 (7–53) 21 (72.4) 8 (27.6) NS (62%), proteinuria, HTN
   Membranoproliferative GN 18 (9.6) 28.9 ± 10.3 (13–54) 9 (50) 9 (50) NS (72%), proteinuria,
     HTN, SCD, NF1
   Membranous glomerulopathy 16 (8.6) 38.4 ± 10.3 (23–62) 10 (62.5) 6 (37.5) NS (68.7%), proteinuria,
     hematuria, ESRD, SCD
   IgA nephropathy 12 (6.4) 31.5 ± 14.6 (7–46) 8 (66.6) 4 (33.4) Proteinuria (50%), NS,
     hematuria, RI, HTN
   Chronic (end-stage) GN 11 (5.9) 36.5 ± 10.4 (21–51) 7 (63.6) 4 (36.4) CRF (45.4%),
     NS, HTN, proteinuria
   Crescentic GN 6 (3.2) 28 ± 8.6 (17–43) 4 (66.7) 2 (33.3) RPGN (66.6%), CRF,
     vasculitis
   IgM nephropathy 3 (1.6) 12 ± 0 (12) 1 (33.3) 2 (66.7) NS, relapsing/steroid-
     dependant
Secondary (n = 46)
   Lupus nephritis 33 (71.7) 23.8 ± 9.2 (13–52) 8 (24.2) 25 (75.8) NS, proteinuria,
     hematuria, HTN, RI
   Diabetic glomerulosclerosis 5 (10.9) 48.4 ± 17 (28–70) 3 (60) 2 (40) CRF, proteinuria, RI
   Amyloidosis 3 (6.5) 42 ± 21.2 (28–50) 1 (33.3) 2 (36.7) NS, CLD (HBV),
     hepatomegaly
   Alport syndrome 2 (4.3) 22 ± 5.6 (18–26) 1 (50) 1 (50) Alport syndrome
   Wegener’s granulomatosis 1 (2.2) (46) 1 0 Hematuria
   Henoch-Schönlein purpura nephritis 1 (2.2) (10) 0 1 Henoch-Schönlein purpura
 Hypertensive nephrosclerosis 1 (2.2) (65) 1 0 Acute/CRF, CAD, HTN, DM
SD = standard deviation; GN = glomerulonephritis; NS = nephrotic syndrome; HTN = hypertension; SCD = sickle cell disease; 
CRF = chronic renal failure; FSGS = focal/segmental glomerulosclerosis; NF1 = neurofibromatosis type 1; ESRD = end-stage renal 
disease; RI = renal impairment; RPGN = rapidly progressive glomerulonephritis; CLD = chronic liver disease; HBV = hepatitis B 
virus; CAD = coronary artery disease; DM = diabetes mellitus.
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microscopy, and immunofluorescence yielded negative 
results. Diffuse fusion and loss of foot processes of 
podocytes was the only abnormality seen on electron 
microscopy.
Mesangioproliferative glomerulonephritis
Patients with mesangioproliferative glomerulonephritis 
ranged between 7 and 70 years old, with a mean age of 
31.5 ± 13.8 years; 19 (51.4%) were male and 18 (48.6%) 
were female. The most common clinical presentation was 
nephrotic syndrome (in 23 patients, equivalent to 62.2% 
of cases), which was steroid dependant/resistant in 8.1% 
(3 patients), and accompanied by hypertension in 10.8% 
(4 patients), hematuria in 8.1% (3 cases), sickle cell 
disease in 5.4% (2 patients) and chronic renal failure in 
2.7% (1 case). Proteinuria was the second most common 
presenting manifestation (seen in 4 patients, equivalent 
to 10.8% of cases). Light microscopy revealed variable 
increase of mesangial cells and matrix in all glomeruli. 
Immunofluorescence showed glomerular deposits of 
IgG, IgM, IgA and C3, singly and in various combina-
tions, mainly in a mesangial location. Electron micros-
copy was not available in any of the cases.
Focal/segmental glomerulosclerosis
Patients with focal/segmental glomerulosclerosis ranged 
between 7 and 53 years of age, with a mean age of 
32 ± 11.8 years; 21 (72.4%) were male and eight (27.6%) 
were female. The most common clinical presentation was 
nephrotic syndrome (in 18 patients, equivalent to 62.1% 
of cases), followed by proteinuria (in 9 patients, 31.0%). 
Associated hypertension was present in 6.9% of cases 
(2 patients). Light microscopy revealed a variable num-
ber of sclerotic segments in a variable number of glom-
eruli. In most cases, the sclerotic segments were few, 
sometimes so few as to be identified only after serial 
sectioning of the specimen. Mild-to-moderate tubular 
atrophy and interstitial fibrosis were observed in two 
cases (6.9%). Immunofluorescence, available in 19 cases, 
yielded negative results in 10 cases (34.5%) while posi-
tive fluorescence was seen in nine (31.0%). The common-
est protein identified was IgM. However, the staining 
was weak, and segmental and focal in distribution.
Membranoproliferative glomerulonephritis
Patients in this group ranged between 13 and 54 years 
of age, with a mean age of 28.9 ± 10.3 years; nine (50%) 
were male and nine (50%) were female. The most com-
mon clinical presentation was nephrotic syndrome (in 13 
patients, equivalent to 72.2% of cases). Proteinuria was 
the second most common presenting manifestation, seen 
in 11.1% (2 patients). Hypertension was also present in 
11.1% (2 patients). An associated sickle cell disease and 
neurofibromatosis type 1 were present in one case each 
(5.6%). Light microscopy revealed irregular, patchy 
thickening of glomerular capillary walls accompanied 
by variable increase of mesangial cells and matrix with 
accentuated glomerular lobulation. Immunofluorescence 
(available in 13 cases) revealed IgG and C3 deposits in 
10 cases (76.9%), IgM in five cases (38.5%), and IgA 
in only one case (7.7%). The pattern of fluorescence was 
diffuse and granular, mainly along the glomerular capil-
lary loops. Electron microscopy was available in two 
cases. It showed interposition of mesangial cell cytoplasm 
between the glomerular basement membrane and the 
endothelial cell cytoplasm with duplication of the base-
ment membrane. There were also subendothelial, sub-
epithelial and intramembranous electron dense deposits 
(membranoproliferative type I, Figure 3).
Membranous glomerulopathy
The age range in this group was 23–62 years, with a 
mean of 38.4 ± 10.3 years; 10 patients (62.5%) were 
male and six (37.5%) were female. The commonest 
clinical presentation was nephrotic syndrome (in 11 
patients, constituting 68.8% of cases), followed by 
proteinuria (in 4 patients, 25.0%) with or without mi-
croscopic hematuria, and finally end-stage renal disease 
(in only 1 case, 6.3%). Sickle cell disease was present 
in one of the patients who presented with proteinuria. 
None of the patients had hepatitis, malignancy or evi-
dence of parasitic infestation. Light microscopy revealed 
variable, uniform, diffuse thickening of glomerular 
capillary walls. Immunofluorescence was available in 
12 cases and showed diffuse granular deposits of IgG 
along the glomerular capillary loops. IgM was also 
present in four cases, IgA in four and C3 in four. Elec-
tron microscopy, available in four cases, showed sub-
epithelial electron dense deposits separated by “spikes” 
or incorporated within the glomerular basement mem-
brane in two cases, and marked irregular thickening of 
the basement membrane in the other two cases (consis-
tent with stage IV membranous glomerulopathy). There 
was also diffuse fusion of epithelial foot processes.
Figure 3. Membranoproliferative glomerulonephritis type I. Electron 
photomicrograph shows “interposition” of mesangial cell cytoplasm 
between endothelial cell and glomerular basement membrane, and 
duplication (splitting) of basement membrane.
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IgA nephropathy
Patients with IgA nephropathy had an age range 
between 7 and 46 years, with a mean age of 31.5 ± 14.6 
years; eight (66.7%) were male and four (33.3%) were 
female. The most common clinical presentation was 
proteinuria (in 6 patients, 50% of cases), followed by neph-
rotic syndrome (in 2 patients, 16.7%), and finally gross 
hematuria (in 1 patient, 8.3%). Associated microscopic 
hematuria was present in three patients (25% of cases) 
and hypertension or renal impairment in two patients 
(16.7%). Immunofluorescence revealed the diagnostic 
finding in all cases of the presence of mesangial IgA 
deposits in all glomeruli (Figure 4). Associated C3 
deposits were found in seven patients (58.3%), IgM in 
four patients (33.3%) and IgG in one patient (8.3%). 
Light microscopic findings ranged from essentially 
normal glomeruli to variable increase of mesangial cells 
and matrix with or without focal, segmental or global 
glomerular sclerosis. Electron microscopy was available 
in four cases. It showed increased mesangial cells and 
matrix accompanied by mesangial electron dense depos-
its and focal fusion of foot processes in one case.
End-stage glomerulopathy (chronic 
glomerulonephritis)
Patients in this group ranged between 21 and 51 years old, 
with a mean age of 36.5 ± 10.4 years; seven (63.6%) were 
male and four (36.4%) were female. Five patients (45.5%) 
presented with chronic renal failure, three (27.3%) with 
nephrotic syndrome, one (9.1%) with hypertension, and 
one (9.1%) with proteinuria. Light microscopy revealed 
global glomerular sclerosis/hyalinosis involving 50% 
or more of the glomeruli accompanied by variable tu-
bular atrophy and interstitial fibrosis and inflammation, 
and hypertensive vascular changes. Immunofluores-
cence, available in four cases, revealed segmental and 
focal deposits of C3, accompanied by IgM deposition 
Figure 4. IgA nephropathy. Note mesangial fluorescence for IgA. 
Direct immunofluorescence (50×).
in one. Electron microscopy was available in two cases, 
showing focal periglomerular fibrosis with no electron 
dense deposits.
Crescentic glomerulonephritis
Patients in this group ranged between 17 and 43 years 
old, with a mean age of 28 ± 8.6 years; four (66.7%) were 
male and two (33.3%) were female. Four patients 
(66.7%) presented with rapidly progressive glomerulo-
nephritis, one (16.7%) with chronic renal failure, and one 
(16.7%) with vasculitis. The main light microscopic 
feature was the presence of large epithelial crescents in 
more than 50% of glomeruli. Immunofluorescence was 
available in two cases, and showed granular deposits of 
IgG, IgA and C3 along the glomerular capillary loops and 
in the mesangium. Electron microscopy was not available 
in any of the cases.
IgM nephropathy
All three patients in this group were 12 years old; one 
patient was male and two were female. Light microscopy 
revealed unremarkable glomeruli or a mild, focal and 
segmental increase of mesangial cells. The clinical pre-
sentation was a relapsing or steroid-dependant nephrotic 
syndrome. Immunofluorescence (available in all cases) 
revealed mesangial IgM deposits, and electron microscopy 
(available in 1 case) revealed focal fusion of epithelial 
foot processes.
Lupus nephritis
Patients with lupus nephritis ranged between 13 and 52 
years of age, with a mean of 23.8 ± 9.2 years; eight 
(24.2%) were male and 25 (75.8%) were female. 
Clinical manifestations included nephrotic syndrome, 
proteinuria, hematuria, hypertension and impairment of 
renal function. One patient also had sickle cell disease. 
Light microscopy, immunofluorescence (available in 
20 cases) and electron microscopy (available in 4 cases) 
revealed World Health Organization Class IV disease 
in 12 patients (36.4%), Class III disease in 11 patients 
(33.3%), Class III progressing to Class IV disease in 
four (12.1%), Class V disease in three (9.1%), and 
Classes I, II, and VI in one patient (3.0%) each.
Diabetic glomerulosclerosis
Of the five patients in this group, three were male (60%) 
and two were female (40%); age ranged from 28 to 70 
years, with a mean of 48.4 ± 17 years. One patient pre-
sented with chronic renal failure, and another with 
proteinuria and chronic renal impairment. The remain-
ing three patients were diabetics with a clinical diagno-
sis of diabetic nephropathy. Light microscopy showed 
nodular glomerulosclerosis in one patient, and mixed 
diffuse and nodular glomerulosclerosis in the other four. 
Hyaline sclerosis of both afferent and efferent glom-
erular arterioles (a finding seen exclusively in diabetic 
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glomerulosclerosis) could also be demonstrated in one 
of these four cases (Figure 5). Immunofluorescence, 
available in one case, showed faint glomerular staining 
for IgA. Electron microscopy, available in another case, 
showed increased mesangial matrix and glomerular 
basement membrane thickening.
Amyloidosis
This was seen in three cases, who all presented with 
nephrotic syndrome, which was associated with chronic 
liver disease due to hepatitis B virus in one patient and 
hepatomegaly in another. Age ranged between 28 and 
50 years, with a mean of 42 ± 21.2 years. One patient was 
male and two were female. Light microscopy revealed 
amyloid deposits in glomeruli and blood vessel walls 
that stained positively for Congo red with apple green 
birefringence elicited by polarized light. Immunofluo-
rescence and electron microscopy were not performed.
Alport syndrome
This was seen in two cases, a 26-year-old male and 
an 18-year-old female with a provisional clinical dia-
gnosis of Alport syndrome based on the association 
of hematuria, mild proteinuria and renal impairment 
with deafness and a positive family history. Light mi-
croscopy revealed focal and segmental glomeruloscle-
rosis with variable thickening of glomerular capillary 
walls and prominent foam cells in the interstitium and 
also within the tubules and glomerular tufts (Figure 6). 
Immunofluorescence and electron microscopy were not 
available. The presence of prominent interstitial foam 
cells in the absence of nephrotic range proteinuria 
strongly supported the clinical impression of Alport 
syndrome.
Wegener’s granulomatosis
This was seen in a 46-year-old male who presented 
with hematuria. Light microscopy revealed a focal and 
segmental proliferative glomerulonephritis with prom-
inent epithelial crescents and few necrotic or sclerotic 
glomerular segments. Immunofluorescence and electron 
microscopy were not available.
Henoch-Schönlein purpura nephritis
This was seen in a 10-year-old female with a provisional 
clinical diagnosis of Henoch-Schönlein purpura. Light 
microscopy revealed a mesangial proliferative glom-
erulonephritis. Immunofluorescence revealed mesangial 
IgA and C3 deposits. Electron microscopy was not 
available.
Hypertensive nephrosclerosis
This was seen in a 65-year-old female with diabetes 
mellitus, hypertension and coronary artery disease who 
presented with acute on top of chronic renal failure. 
Light microscopy revealed hyaline arteriolosclerosis, 
arteriolar myointimal hyperplasia, focal glomerular 
sclerosis and interstitial fibrosis. Immunofluorescence 
and electron microscopy were not available.
DISCUSSION
Identification of the pattern of glomerular disease in a 
particular geographic location is of fundamental impor-
tance. It may help recognition of specific risk factors 
for glomerular disease and aid subsequent planning for 
possible prevention.
Studies published so far from different countries as 
well as from a number of centers in Saudi Arabia have 
reported conflicting results with regard to the prevalence 
of the different types of glomerular lesions. Possible rea-
sons for the discrepancies include environmental or racial 
(genetic) factors, the small number of patients in some of 
the studies, differences in the indications for renal biop-
sies, and the non-availability of all necessary diagnostic 
Figure 5. Diabetic glomerulosclerosis. Note hyaline sclerosis of both 
afferent and efferent arterioles (hematoxylin & eosin, 100×).
Figure 6. Alport syndrome. Note prominent interstitial foam cells 
(hematoxylin & eosin, 200×).
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Table 2. Prevalence of glomerular diseases compared to that reported by other centers in Saudi Arabia
 Present Saudi Alkhunaizi Bernieh Mousa Mitwalli Al-Homrany Akhtar Huraib
 study Registry [2] [3] et al [4] et al [5] et al [6] [7] et al [8] et al [9]
Place of study KFHU Six referral DHC,  Madinah AFH KKUH ACH KFSH KKUH
 Al-Khobar hospitals Aramco region Riyadh Riyadh Abha Riyadh Riyadh
   Dhahran
Period of study 1986–2008 – 1998–2005 – 1 year 1994–1999 1989–1997 1983–1988 1980–1988
Primary GN (%)         
   MCG 29.4 11.5 10 29 –  8.6  9.9 5.8 21.8
   MsPGN 19.8 16.3 6 15.3 20.4 25.1  4.5 29 8
   FSGS 15.5 21.3 35 15.3 31 34.6 17.1 34.9 11.4
   MPGN 9.6 20.7 4 8.2 2 15.7 38.7 – 26.4
   MG 8.6 10.6 4 3.2 –  3.9 9 6.5 21.8
   IgAN 6.4 6.5 14 – 14.5 10.2 18.9 5.8
Secondary GN (%)
   LN 71.7 57 36 15.3 – 55 61.5 46.7 53.6
   DGS 10.9 7.5 14 – – 5.6 – 5.1  7.3
   AMD 6.5 3.2 – 2.4 – – – – 
   HSP 2.2 2.3 – – – 1.1  9  4.8
   HTNS 2.2 5.9 11 – – 3.3 – 9 17.6
KFHU = King Fahd Hospital of the University; DHC = Dhahran Health Center; AFH = Armed Forces Hospital; KKUH = King Khaled 
University Hospital; ACH = Abha Central Hospital; KFSH = King Faisal Specialist Hospital; GN = glomerulonephritis; MCG = minimal 
change glomerulopathy; MsPGN = mesangioproliferative glomerulonephritis; FSGS = focal segmental glomerulosclerosis; MPGN = mem-
branoproliferative glomerulonephritis; MG = membranous glomerulonephritis; IgAN = IgA nephropathy; LN = lupus nephritis; 
DGS = diabetic glomerulosclerosis; AMD = amyloidosis; HSP = Henoch-Schönlein purpura; HTNS = hypertensive nephrosclerosis.
Table 3. Prevalence of glomerular diseases compared to that reported in countries other than Saudi Arabia
 Present Narasimhan Al Arrayed  Rychlík  Shaker  Barsoum &  Said  Chan  Stratta 
 study, et al, et al, et al, et al, Francis, et al, et al, et al,
 2010 2006 [10] 2004 [11] 2004 [12] 2002 [13] 2000 [14] 2000 [15] 1999 [16] 1996 [17]
 KFHU India Bahrain Czech Iraq Egypt Jordan Hong Kong ItalyPlace of study Al-Khobar   Republic
Primary GN (%)
   MCG 29.4 11.6 30.0 12.4 17.1 – – 8.8 5.9
   MsPGN 19.8 20.2 – 11.3 22.5 – – – –
   FSGS 15.5 17.0 23.8 10.8 26.3 22.6 27.1 – 7.8
   MPGN 9.6 3.7 14.3 – 16.2 – 35.0 – 7.3
   MG 8.6 9.8 – 9.3 14.5 – – – 20.0
   IgAN 6.4 8.6 – 34.5 0  9.8 – 23.9 26.0
Secondary GN (%)
   LN 71.7 6.5 38.9 23.0 45.5 – 38.8 – –
   DGS 10.9 2.5 31.9  14.5 – – – –
   AMD 6.5 – – 9.9 27.3 – 40.7 – –
   HSP 2.2 – – 5.7 – – – – –
   HTNS 2.2 2.2 20.4 – 1.8 – – – –
KFHU = King Fahd Hospital of the University; GN = glomerulonephritis; MCG = minimal change glomerulopathy; MsPGN = mesan-
gioproliferative glomerulonephritis; FSGS = focal segmental glomerulosclerosis; MPGN = membranoproliferative glomerulone-
phritis; MG = membranous glomerulonephritis; IgAN = IgA nephropathy; LN = lupus nephritis; DGS = diabetic glomerulosclerosis; 
AMD = amyloidosis; HSP = Henoch-Schönlein purpura; HTNS = hypertensive nephrosclerosis.
facilities in some of the reporting centers [2]. Tables 2 
and 3 and Figures 7–10 show the prevalence of the more 
common glomerular diseases encountered in the present 
study as compared to the prevalence reported by other 
centers in Saudi Arabia as well as in some other parts of 
the world, including neighboring countries [2–17].
Other than a significantly higher incidence of minimal 
change glomerulopathy (29.4% of primary glomerular 
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Figure 7. Prevalence of primary glomerular diseases compared 
to that reported by other centers in Saudi Arabia. A 100% 
stacked column chart comparing the prevalence of each type of 
primary glomerulonephritis to a total across various centers 
in Saudi Arabia. MCG = minimal change glomerulopathy; 
MsPGN = mesangioproliferative glomerulonephritis; FSGS = focal 
segmental glomerulosclerosis; MPGN = membranoproliferative 
glomerulonephritis; MG = membranous glomerulonephritis; 
IgAN = IgA nephropathy; KFHU = King Fahd Hospital of the 
University; DHC = Dhahran Health Center; AFH = Armed Forces 
Hospital; KKUH = King Khaled University Hospital; ACH = Abha 
Central Hospital; KFSH = King Faisal Specialist Hospital.
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Figure 8. Prevalence of secondary glomerular diseases compared 
to that reported by other centers in Saudi Arabia. A 100% stacked 
column chart comparing the prevalence of each type of secondary 
glomerulonephritis to a total across various centers in Saudi 
Arabia. LN = lupus nephritis; DGS = diabetic glomerulosclerosis; 
AMD = amyloidosis; HSP = Henoch-Schönlein purpura; HTNS = 
hypertensive nephrosclerosis; KFHU = King Fahd Hospital of the 
University; DHC = Dhahran Health Center; KKUH = King Khaled 
University Hospital; ACH = Abha Central Hospital; KFSH = King 
Faisal Specialist Hospital.
disease in the present study vs. 11.5% reported by the 
registry, p < 0.001) and lupus nephritis (71.7% of sec-
ondary glomerular disease vs. 57%, p < 0.001), and a 
significantly lower prevalence of membranoproliferative 
glomerulonephritis (9.6% of primary glomerular disease 
vs. 20.7%, p = 0.029), our results are generally com-
parable to those reported by the Saudi registry for 
glomerulopathy [2] and in neighboring countries 
[11,13–16]. It should be noted that the study of the Saudi 
registry published in the year 2000 included 131 of the 
glomerulonephritis cases included in the present study. 
Age- and sex-adjusted analyses revealed that minimal 
change glomerulopathy and lupus nephritis were also 
the most prevalent primary and secondary glomerul-
opathies in the pediatric age group as well as in adults, 
females and males.
In agreement with the present study, minimal change 
glomerulopathy was reported to be the leading primary 
glomerular disease in the Madinah region of Saudi 
Arabia [4] and also in Bahrain [11], amounting to 29% 
and 30% of cases, respectively. It is interesting to note 
that Bahrain is the closest country to Eastern Saudi 
Arabia and that the people of both regions have the same 
ethnic roots and are strongly tied by tribal and family 
kinship. Could genetic factors underlie the prevalence 
of minimal change glomerulopathy in both regions?
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Figure 9. Prevalence of primary glomerular diseases compared 
to that reported in countries other than Saudi Arabia. A 
100% stacked column chart comparing the prevalence of 
each type of primary glomerulonephritis to a total across 
various countries. MCG = minimal change glomerulopathy; 
MsPGN = mesangioproliferative glomerulonephritis; FSGS = focal 
segmental glomerulosclerosis; MPGN = membranoproliferative 
glomerulonephritis; MG = membranous glomerulonephritis; 
IgAN = IgA nephropathy; KFHU = King Fahd Hospital of the 
University.
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Figure 10. Prevalence of secondary glomerular diseases compared to 
that reported in countries other than Saudi Arabia. A 100% stacked 
column chart comparing the prevalence of each type of secondary 
glomerulonephritis to a total across various countries. LN = lupus 
nephritis; DGS = diabetic glomerulosclerosis; AMD = amyloidosis; 
HSP =  Henoch-Schönlein purpura; HTNS =  hypertensive 
nephrosclerosis; KFHU = King Fahd Hospital of the University.
Lupus nephritis was frequent in the present study 
(75% of secondary glomerular diseases), probably be-
cause all the cases studied were known cases of systemic 
lupus erythematosus biopsied for the purpose of estab-
lishing a diagnosis of lupus nephritis or grading and 
staging of an already diagnosed lupus nephritis.
The lower prevalence of membranoproliferative 
glomerulonephritis in the present study and also in most 
of the studies reported from the Kingdom [3–5] (Table 3) 
may be attributed to the non-availability of immunofluo-
rescence and electron microscopy in a number of the 
cases studied, so that early cases (where mesangial hy-
percellularity and glomerular capillary wall thickening 
may be too slight to be recognized by light microscopy) 
could have been misinterpreted as minimal change 
glomerulopathy or mild mesangioproliferative glom-
erulonephritis [18].
Finally, a markedly lower incidence of IgA neph-
ropathy has been noted in the present study as well as 
in most of the studies reported from Saudi Arabia [2,6,8] 
and from neighboring countries [13,14], as compared 
to its incidence in other parts of the world where IgA 
nephropathy has generally been the leading primary 
glomerular disease [12,16,17] (Tables 2 & 3). This again 
may be attributed to the non-availability of immuno-
fluorescence in all of the glomerular biopsies studied. 
Without immunofluorescence, IgA nephropathy can be 
mistaken morphologically as well as clinically for almost 
any type of glomerulonephritis.
It is clear from the above discussion that without 
performing immunofluorescence and electron microscopy 
on every renal biopsy evaluated for suspected glomerular 
disease, a precise typing of the glomerular disease may 
not be possible on the basis of light microscopy alone. 
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This may be the main reason for the discrepancies in 
the prevalence of the different types of glomerular le-
sions in different reports, particularly those from Saudi 
Arabia and other countries in the region where these 
facilities are not available in all laboratories.
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